Mikael Schwarz

852 total citations
16 papers, 680 citations indexed

About

Mikael Schwarz is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Mikael Schwarz has authored 16 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Computational Theory and Mathematics. Recurrent topics in Mikael Schwarz's work include Cholinesterase and Neurodegenerative Diseases (5 papers), Computational Drug Discovery Methods (4 papers) and Pesticide Exposure and Toxicity (3 papers). Mikael Schwarz is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (5 papers), Computational Drug Discovery Methods (4 papers) and Pesticide Exposure and Toxicity (3 papers). Mikael Schwarz collaborates with scholars based in Israel, United Kingdom and Denmark. Mikael Schwarz's co-authors include Hermona Soreq, David Glick, Nir Dotan, A. Dukler, Yael Loewenstein, Bent Nørgaard‐Pedersen, Larissa Spector, H Zakut, Mark Harlow and Peter Jenner and has published in prestigious journals such as Nature Medicine, PLANT PHYSIOLOGY and Journal of Neurochemistry.

In The Last Decade

Mikael Schwarz

16 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikael Schwarz Israel 12 278 196 109 104 100 16 680
Hiroko Miyadera Japan 18 612 2.2× 154 0.8× 67 0.6× 57 0.5× 31 0.3× 37 1.3k
Thomas H. Hudson United States 20 466 1.7× 138 0.7× 200 1.8× 28 0.3× 30 0.3× 23 1.1k
Cláudia Barbosa Ladeira de Campos Brazil 13 336 1.2× 58 0.3× 36 0.3× 44 0.4× 77 0.8× 32 709
Carsten Zeilinger Germany 18 567 2.0× 111 0.6× 86 0.8× 154 1.5× 17 0.2× 50 880
Ian Tietjen United States 19 629 2.3× 74 0.4× 105 1.0× 61 0.6× 29 0.3× 58 1.2k
Ping Bai China 20 532 1.9× 298 1.5× 134 1.2× 50 0.5× 16 0.2× 73 1.2k
Chun‐Chen Chen Taiwan 12 386 1.4× 51 0.3× 190 1.7× 27 0.3× 80 0.8× 28 908
Tim Young United Kingdom 10 353 1.3× 542 2.8× 123 1.1× 100 1.0× 18 0.2× 13 1.1k
Manuela Grimaldi Italy 17 342 1.2× 86 0.4× 84 0.8× 37 0.4× 17 0.2× 54 686
Shalini Singh India 22 406 1.5× 84 0.4× 137 1.3× 159 1.5× 9 0.1× 59 1.1k

Countries citing papers authored by Mikael Schwarz

Since Specialization
Citations

This map shows the geographic impact of Mikael Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Schwarz more than expected).

Fields of papers citing papers by Mikael Schwarz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Schwarz. The network helps show where Mikael Schwarz may publish in the future.

Co-authorship network of co-authors of Mikael Schwarz

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Schwarz. A scholar is included among the top collaborators of Mikael Schwarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Schwarz. Mikael Schwarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Khan, Sujoy, et al.. (2008). Some cases of common variable immunodeficiency may be due to a mutation in the SBDS gene of Shwachman–Diamond syndrome. Clinical & Experimental Immunology. 151(3). 448–454. 15 indexed citations
2.
Schwarz, Mikael, Larissa Spector, Lea Glass‐Marmor, et al.. (2006). Serum anti-Glc(α1,4)Glc(α) antibodies as a biomarker for relapsing–remitting multiple sclerosis. Journal of the Neurological Sciences. 244(1-2). 59–68. 49 indexed citations
3.
Dotan, Nir, et al.. (2006). Anti-Glycan Antibodies as Biomarkers for Diagnosis and Prognosis. Lupus. 15(7). 442–450. 75 indexed citations
4.
Schwarz, Mikael, et al.. (2003). Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism. Pharmacology Biochemistry and Behavior. 75(3). 627–633. 76 indexed citations
6.
Ress, David, et al.. (1999). Automatic acquisition of fiducial markers and alignment of images in tilt series for electron tomography. Journal of Electron Microscopy. 48(3). 277–287. 62 indexed citations
7.
Cohen, Dani, Mikael Schwarz, James W. LeDuc, et al.. (1999). Prevalence of antibodies to West Nile fever, sandfly fever Sicilian, and sandfly fever Naples viruses in healthy adults in Israel.. PubMed. 27(1-3). 217–30. 40 indexed citations
8.
Harlow, Mark, David Ress, Abraham J. Koster, et al.. (1998). Dissection of active zones at the neuromuscular junction by EM tomography. Journal of Physiology-Paris. 92(2). 75–78. 14 indexed citations
9.
Wang, Weiguang, Santhosh Kumar Pasupuleti, Justin P. Whalley, et al.. (1998). The mutation status of PAX3 and p53 genes in medulloblastoma.. PubMed. 18(2A). 849–53. 9 indexed citations
10.
Schwarz, Mikael, et al.. (1995). Genetic predisposition to adverse consequences of anti–cholinesterases in ‘atypical’ BCHE carriers. Nature Medicine. 1(10). 1082–1085. 89 indexed citations
11.
Schwarz, Mikael, David Glick, Yael Loewenstein, & Hermona Soreq. (1995). Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. Pharmacology & Therapeutics. 67(2). 283–322. 78 indexed citations
12.
Schwarz, Mikael, et al.. (1995). Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants. Molecular Brain Research. 31(1-2). 101–110. 30 indexed citations
13.
Gnatt, Averell, Yael Loewenstein, Avraham Yaron, Mikael Schwarz, & Hermona Soreq. (1994). Site‐Directed Mutagenesis of Active Site Residues Reveals Plasticity of Human Butyrylcholinesterase in Substrate and Inhibitor Interactions. Journal of Neurochemistry. 62(2). 749–755. 22 indexed citations
14.
Ehrlich, Gal, et al.. (1994). Mutations and impaired expression in the ACHE and BCHE genes: neurological implications. Biomedicine & Pharmacotherapy. 48(5-6). 253–259. 5 indexed citations
15.
Bauer-Hofmann, R., Stefan Kress, & Mikael Schwarz. (1992). Identification of point mutations at codon 61 of the c-Ha-ras gene by single-strand conformation polymorphism analysis.. PubMed. 13(2). 192–4. 2 indexed citations
16.
Schwarz, Mikael, Henri R. Lerner, & Leonora Reinhold. (1991). Mitochondria Isolated from NaCl-Adapted Tobacco Cell Lines (Nicotiana tabacum/gossii) Maintain Their Phosphorylative Capacity in Highly Saline Media. PLANT PHYSIOLOGY. 96(1). 69–76. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026